Auxier Asset Management’s AbbVie ABBV Stock Holding History

Auxier Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.75M	Sell	31,054 -143	-0.5%	-$31.7K	0.97%	34
2025 Q4	$7.13M	Sell	31,197 -293	-0.9%	-$66.7K	1%	32
2025 Q3	$7.29M	Sell	31,490 -1,326	-4%	-$270K	1.02%	32
2025 Q2	$6.09M	Sell	32,816 -190	-0.6%	-$35.3K	0.89%	35
2025 Q1	$6.92M	Buy	33,006 +800	+2%	+$156K	1.03%	32
2024 Q4	$5.72M	Sell	32,206 -1,233	-4%	-$227K	0.89%	37
2024 Q3	$6.6M	Sell	33,439 -250	-0.7%	-$46.7K	0.98%	35
2024 Q2	$5.78M	Hold	33,689	–	–	0.91%	37
2024 Q1	$6.13M	Sell	33,689 -1,713	-5%	-$295K	0.93%	34
2023 Q4	$5.49M	Sell	35,402 -833	-2%	-$121K	0.89%	37
2023 Q3	$5.4M	Sell	36,235 -1,040	-3%	-$153K	0.92%	35
2023 Q2	$5.02M	Buy	37,275 +2,384	+7%	+$350K	0.83%	39
2023 Q1	$5.56M	Sell	34,891 -407	-1%	-$62.2K	0.96%	35
2022 Q4	$5.7M	Sell	35,298 -90	-0.3%	-$13.8K	0.98%	33
2022 Q3	$4.75M	Sell	35,388 -250	-0.7%	-$35.9K	0.92%	35
2022 Q2	$5.46M	Sell	35,638 -55	-0.2%	-$8.4K	0.97%	31
2022 Q1	$5.79M	Sell	35,693 -34	-0.1%	-$4.94K	0.92%	35
2021 Q4	$4.84M	Sell	35,727 -126	-0.4%	-$14.9K	0.75%	44
2021 Q3	$3.87M	Sell	35,853 -179	-0.5%	-$20.5K	0.65%	49
2021 Q2	$4.06M	Sell	36,032 -300	-0.8%	-$33.8K	0.67%	49
2021 Q1	$3.93M	Sell	36,332 -850	-2%	-$90.9K	0.68%	50
2020 Q4	$3.98M	Buy	37,182 +620	+2%	+$59.6K	0.74%	44
2020 Q3	$3.2M	Buy	36,562 +1,020	+3%	+$96K	0.67%	49
2020 Q2	$3.49M	Buy	35,542 +7,152	+25%	+$630K	0.77%	43
2020 Q1	$2.16M	Sell	28,390 -120	-0.4%	-$10.2K	0.54%	55
2019 Q4	$2.52M	Sell	28,510 -150	-0.5%	-$12.5K	0.47%	64
2019 Q3	$2.17M	Buy	28,660 +10	+0%	+$686	0.44%	66
2019 Q2	$2.08M	Buy	28,650 +1,150	+4%	+$90.4K	0.42%	71
2019 Q1	$2.22M	Buy	27,500 +825	+3%	+$67.5K	0.46%	65
2018 Q4	$2.46M	Sell	26,675 -100	-0.4%	-$8.79K	0.55%	55
2018 Q3	$2.53M	Buy	26,775 +4,200	+19%	+$398K	0.48%	62
2018 Q2	$2.09M	Sell	22,575 -50	-0.2%	-$4.88K	0.42%	69
2018 Q1	$2.14M	Sell	22,625 -100	-0.4%	-$11K	0.43%	66
2017 Q4	$2.2M	Sell	22,725 -50	-0.2%	-$4.71K	0.42%	69
2017 Q3	$2.02M	Sell	22,775 -50	-0.2%	-$3.81K	0.41%	66
2017 Q2	$1.66M	Hold	22,825	–	–	0.34%	74
2017 Q1	$1.49M	Buy	22,825 +2,000	+10%	+$126K	0.31%	78
2016 Q4	$1.3M	Buy	20,825 +203	+1%	+$12.4K	0.28%	85
2016 Q3	$1.3M	Sell	20,622 -50	-0.2%	-$3.24K	0.29%	82
2016 Q2	$1.28M	Buy	20,672 +100	+0.5%	+$6.09K	0.29%	80
2016 Q1	$1.18M	Buy	20,572 +300	+1%	+$16.7K	0.28%	81
2015 Q4	$1.2M	Hold	20,272	–	–	0.27%	83
2015 Q3	$1.1M	Buy	20,272 +1,101	+6%	+$71.7K	0.26%	88
2015 Q2	$1.29M	Hold	19,171	–	–	0.27%	89
2015 Q1	$1.12M	Sell	19,171 -7,900	-29%	-$477K	0.23%	95
2014 Q4	$1.77M	Sell	27,071 -300	-1%	-$18.9K	0.35%	72
2014 Q3	$1.58M	Sell	27,371 -46,050	-63%	-$2.56M	0.33%	78
2014 Q2	$4.14M	Sell	73,421 -5,019	-6%	-$263K	0.85%	43
2014 Q1	$4.03M	Hold	78,440	–	–	0.86%	44
2013 Q4	$4.14M	Sell	78,440 -2,000	-2%	-$98.3K	0.87%	44
2013 Q3	$3.6M	Hold	80,440	–	–	0.83%	48
2013 Q2	$3.33M	Buy	+80,440	New	+$3.52M	0.8%	46

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Auxier Asset Management's ABBV Position: Q1 2026 in Review

Auxier Asset Management reduced its AbbVie (ABBV) stake by 0.46% in Q1 2026, selling an estimated $31.7K and leaving 31,054 shares worth $6.75M. The position accounts for 0.97% of the portfolio, ranked #34.

Auxier Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.29M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Auxier Asset Management held 31,054 shares of AbbVie worth $6.75M as of Q1 2026.
Auxier Asset Management sold 143 AbbVie shares in Q1 2026, an estimated $31.7K.
AbbVie made up 0.97% of Auxier Asset Management's portfolio in Q1 2026, its #34 holding.
Auxier Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Auxier Asset Management's AbbVie position peaked at $7.29M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.